Welcome to our dedicated page for Transphorm news (Ticker: TGAN), a resource for investors and traders seeking the latest updates and insights on Transphorm stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Transphorm's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Transphorm's position in the market.
Transphorm, Inc. (OTCQB: TGAN) has expanded its cooperation agreement with Yaskawa Electric Corporation, with Yaskawa committing $4 million in investments. The first tranche of $1 million is expected by mid-December 2020. This agreement builds upon a previous partnership starting in 2017, which saw Yaskawa invest $15 million in Transphorm. The collaboration aims to utilize Transphorm's GaN power devices for industrial applications, enhancing Yaskawa's next-generation products in servo motors and variable frequency drives.